Celldex Therapeutics, Inc. has grown revenue −64% a year over three years and −55% a year over five. Revenue growth, 3-year annual rate: −64% (Biotechnology median +21%). Revenue growth, 5-year rate: −55%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

CLDXCelldex Therapeutics, Inc.

HealthcareUSD

$40.57

$20.0152 weeks$44.88

Is it growing?

Is CLDX growing?

Celldex Therapeutics, Inc. has grown revenue −64% a year over three years and −55% a year over five.

−64%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −55%
Revenue growth, 5-year rate · −64% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›